⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,828.02
−0.40%
FTSE ADX
9,827.88
+0.46%
TASI
9,952.50
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.62
+0.38%
ADX:IHC
AED 357.10
+1.45%
SAU:2222
SAR 25.54
−1.01%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,118.95
−0.53%
Brent
$111.38
+1.98%
BTC
$81,434.65
−0.50%
ETH
$2,382.40
−0.95%
DFM General
5,828.02
−0.40%
FTSE ADX
9,827.88
+0.46%
TASI
9,952.50
−1.69%
QE Index
8,598.42
−0.40%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,151.64
−0.49%
DFM:EMIRATESNBD
AED 31.62
+0.38%
ADX:IHC
AED 357.10
+1.45%
SAU:2222
SAR 25.54
−1.01%
DSMD:QNBK
QAR 15.55
−0.70%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.01
+0.18%
Gold
$4,118.95
−0.53%
Brent
$111.38
+1.98%
BTC
$81,434.65
−0.50%
ETH
$2,382.40
−0.95%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› REGN
R
Regeneron Pharmaceuticals Inc
NAS:REGN
Healthcare
CBOE:SPESG
NASDAQ:NBI
$782.04
−1.10%
At close
At close · Tue 20 Oct · ≈
AED 2,872.04
· Market cap
$80.51B
· Next earnings
Wed 28 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
Regeneron Pharmaceuticals Inc · News · TradingHolo
REGN news
Headlines tagged to this company
TR
Weekly Recap: EYLEA, DUPIXENT and LIBTAYO growth and Q3 2026 results
TradingView · 22 d ago
GL
Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026
globenewswire · 26 d ago
SE
Healthcare stocks with the strongest dividend growth grades
seekingalpha · 29 d ago
SE
Trump set to announce MFN pricing for Medicaid in all states
seekingalpha · 32 d ago
SE
Alvotech wins double upgrade at Barclays on upcoming FDA decision
seekingalpha · 34 d ago
SE
FDA launches pilot program that aims to speed the time to first-in-human drug trials
seekingalpha · 35 d ago
SE
Astra, Roche win new Outperform ratings as RBC initiates EU pharma coverage
seekingalpha · 41 d ago
PR
REGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses
PRNewsWire · 62 d ago
GL
Regeneron Announces Investor Conference Presentations
GlobeNewsWire · 62 d ago
NE
Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
Newsfile Corp · 62 d ago
RE
US FDA approves Regeneron's rare bone disorder drug
Reuters · 62 d ago
GL
Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva (FOP)
GlobeNewsWire · 62 d ago
PR
REGN Investor Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Notice - Contact Levi & Korsinsky
PRNewsWire · 62 d ago
GL
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewsWire · 62 d ago
NE
REGN EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron (REGN) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
Newsfile Corp · 62 d ago
GL
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
GlobeNewsWire · 63 d ago
GL
REGN Deadline Alert: SueWallSt Reminds Regeneron Pharmaceuticals (REGN) Investors of Securities Class Action Deadline on September 14, 2026
GlobeNewsWire · 63 d ago
PR
REGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
PRNewsWire · 63 d ago
GL
Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
GlobeNewsWire · 64 d ago
NE
REGN CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
Newsfile Corp · 64 d ago
← Previous
More news →